Amphenol (APH) Tops Q2 EPS by 3c, provides guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mail
Get Alerts APH Hot Sheet
Price: $79.01 -6.15%
Financial Fact:
Net income per common share - Diluted (in dollars per share): 0.71
Today's EPS Names:
COHR, ATS, SICP, More
Financial Fact:
Net income per common share - Diluted (in dollars per share): 0.71
Today's EPS Names:
COHR, ATS, SICP, More
Join SI Premium – FREE
Amphenol (NYSE: APH) reported Q2 EPS of $0.44, $0.03 better than the analyst estimate of $0.41. Revenue for the quarter came in at $3.61 billion versus the consensus estimate of $3.38 billion.
GUIDANCE:
Amphenol sees Q3 2024 EPS of $0.43-$0.45, versus the consensus of $0.44.
For earnings history and earnings-related data on Amphenol (APH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Veracyte (VCYT) Tops Q3 EPS by 10c ; Offers Guidance
- Revolution Medicines, Inc. (RVMD) Tops Q3 EPS by 45c ; Provides Outlook
- Kotak Upgrades Niva Bupa Health Insurance (NIVABUPA:IN) to Buy (1)
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
